PRL and breast carcinoma: In cell line-based assay involving breast cancer cells (MCF-7 and T47D), it has been found that the PRL/PRLR triggers EGFR2 phosphorylation (tyr1221 and 1222) via JAK2, activating the downstream PI3K/AKT signaling [26].